Should I buy Synopsys (SNPS) stock or is it too late?

Synopsys · Information Technology · price $495

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Rosenblatt — 73% of its targets hit on this sector (560 calls tested). It aims for $620 (+25 %), call made on October 2, 2026, maturing on October 2, 2027 (12 d ago).

The 9 reliable analysts $570+15 %

The 5 other firms $600+21 %

How to read it: the 9 reliable firms are not filtered by optimism — 9 aim above the price, 0 below, hence their $570 median. “The 5 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Synopsys

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
Wells Fargo	85 %	+28.6 %	20	$540 +9%
Baird	76 %	+25.2 %	21	$560 +13%
Keybanc	82 %	+23.1 %	33	$605 +22%
JP Morgan	78 %	+21.5 %	9	$650 +31%
B of A Securities	90 %	+18.0 %	20	$600 +21%
Rosenblatt	67 %	+12.7 %	27	$620 +25%
Stifel	100 %	+12.3 %	7	$600 +21%
Needham	64 %	+11.5 %	25	$620 +25%

In short — Should you invest in Synopsys? Is it too late, still worth it? Analysts are overwhelmingly positive (93% buy, median target $585, i.e. +18%), and the most reliable on SNPS targets even higher. But the valuation is stretched (P/E ~87), the stock is volatile, it pays virtually no dividend. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

93% of analysts rate it a buy (Buy consensus, 14 ratings) — a sign of market conviction.
Median price target $585, i.e. +18% from the current price ($495).
The most reliable firm on SNPS, Stifel (100% hit rate, 7 scored calls), targets $600 (call made on May 28, 2026, maturing on May 28, 2027) (+21%) in its most recent call.
8 analysts rated reliable (≥55% hit rate, beat their sector) are bullish on the stock.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 14 ratings, 1 is neutral.
High valuation (P/E ~87): strong growth is already "priced in", leaving little room for error.
A 12-month target is not a guaranteed path: the price can fall in the meantime.
Volatile stock: sharp swings — including steep drops — are part of its profile.
No dividend: your return depends only on price appreciation.

The analyst consensus on SNPS

Median target $585 (+18%) · 14 ratings · Buy consensus

Strong Buy00%

Buy1393%

Hold17%

Sell00%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Synopsys now?

We won't decide for you. The facts: 93% of analysts rate it a buy, median target $585 (+18%), and Stifel (most reliable on SNPS, 100%) targets $600. Weigh that against valuation (P/E ~87) and volatility. This is not personalized advice.

Is it too late to invest in Synopsys?

Not according to analysts: the median target ($585) is still +18% above the current price ($495) (most reliable on SNPS: Stifel, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Synopsys still worth investing in?

It depends on the gap between the price ($495) and its estimated value: analysts target $585 on median (+18%), with 93% buys (most reliable on SNPS: Stifel, 100%). Cross-check with their real reliability on SNPS and the cautions above. Information, not advice.

What's the main risk in buying SNPS?

The consensus is not unanimous: of 14 ratings, 1 is neutral.

→ Go deeper: the full Synopsys profile (consensus, analyst reliability, price target, performance).